In epidemiological studies of type 2 diabetes, it has been consistently observed that the addition of insulin to the treatment regimen or the intensification of insulin treatment result in a higher rate of cardiovascular events [102–121] (Fig. 5). Here, INS is linked to type 2 diabetes mellitus.